Capital Advisors, Ltd. LLC Dexcom Inc Transaction History

Capital Advisors, Ltd. LLC

$759 Million
Q1 2025

A detailed history of Capital Advisors, Ltd. LLC transactions in Dexcom Inc stock. As of the latest transaction made, Capital Advisors, Ltd. LLC holds 504 shares of DXCM stock, worth $35,975. This represents 0.0% of its overall portfolio holdings.

Number of Shares

504

Previous 491 2.65%

Holding current value

$35,975

Previous $38,000 10.53%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 15, 2025	BUY	$67.74 - $90.75 $880 - $1,179	13 Added 2.65%	504 $34,000
Q4 2024 Feb 04, 2025	SELL	$65.68 - $81.01 $8,998 - $11,098	-137 Reduced 21.82%	491 $38,000
Q3 2024 Oct 24, 2024	BUY	$64.0 - $116.06 $4,928 - $8,936	77 Added 13.97%	628 $42,000
Q2 2024 Jul 25, 2024	BUY	$110.31 - $140.45 $330 - $421	3 Added 0.55%	551 $62,000
Q1 2024 Apr 18, 2024	BUY	$114.22 - $140.1 $799 - $980	7 Added 1.29%	548 $76,000
Q4 2023 Feb 02, 2024	BUY	$75.49 - $124.16 $1,811 - $2,979	24 Added 4.64%	541 $67,000
Q3 2023 Oct 27, 2023	SELL	$86.06 - $137.93 $258 - $413	-3 Reduced 0.58%	517 $48,000
Q2 2023 Jul 26, 2023	BUY	$112.47 - $130.98 $55,222 - $64,311	491 Added 1693.1%	520 $67,000
Q1 2023 May 03, 2023	SELL	$104.0 - $122.92 $51,064 - $60,353	-491 Reduced 94.42%	29 $3,000
Q4 2022 Feb 07, 2023	BUY	$84.98 - $122.67 $41,725 - $60,230	491 Added 1693.1%	520 $4,000
Q3 2022 Nov 09, 2022	BUY	$76.35 - $94.18 $610 - $753	8 Added 38.1%	29 $2,000
Q2 2022 Aug 05, 2022	BUY	$67.99 - $132.89 $1,427 - $2,790	21 New	21 $2,000
Q1 2022 May 09, 2022	SELL	$94.08 - $130.2 $188 - $260	-2 Closed	0 $0
Q4 2021 Feb 08, 2022	BUY	$129.87 - $162.82 $259 - $325	2 New	2 $1,000

Others Institutions Holding DXCM

# of Institutions

1,079

Shares Held

354M

Call Options Held

8.45M

Put Options Held

5.75M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $27.6B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Advisors, Ltd. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Advisors, Ltd. LLC with notifications on news.

Account

Capital Advisors, Ltd. LLC Dexcom Inc Transaction History